Reward and affective regulation in depression-prone smokers

Biological Psychiatry

Volumn 76, Issue 9, 2014, Pages 689-697

  Audrain McGovern, Janet ^a,b   Wileyto, E Paul ^a   Ashare, Rebecca ^a   Cuevas, Jocelyn ^a   Strasser, Andrew A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Cancer Center   (United States)

Author keywords

Depression; Negative affect; Positive affect; Reward regulation; Reward sensitivity; Smoking

Indexed keywords

ADULT; AFFECT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; MONEY; NORMAL HUMAN; PRIORITY JOURNAL; REINFORCEMENT; REWARD; SELF REPORT; SIGNAL DETECTION; SMOKING; SMOKING CESSATION; TASK PERFORMANCE; DECISION MAKING; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADULT; CHOICE BEHAVIOR; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; SELF REPORT; SMOKING; SMOKING CESSATION; TOKEN ECONOMY; YOUNG ADULT;

EID: 84922630092     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.04.018     Document Type: Article

References (114)

1. Cinciripini PM, Tsoh JY, Wetter DW, Lam C, de Moor C, Cinciripini L, et al. (2005): Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation. Exp Clin Psychopharmacol 13:282-292.
2. Ginsberg D, Hall SM, Reus VI, Munoz RF (1995): Mood and depression diagnosis in smoking cessation. Exp Clin Psychopharmacol 3:389-395.
3. Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB, Covey LS (1988): Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 259:2863-2866.
4. Hall SM, Munoz RF, Reus VI (1994): Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol 62:141-146.
5. Hall SM, Reus VI, Munoz RF, Sees KL, Humfleet G, Hartz DT, et al. (1998): Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 55:683-690.
6. Substance Abuse and Mental Health Services Administration (2004): Office of Applied Studies, National Survey on Drug Use and Health, Subsample. Available at: http://www.samhsa.gov/data/nsduh/2k4nsduh/2k4results/2k4results.pdf.
7. Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA (2013): The relationship of dysthymia, minor depression, and gender to changes in smoking for current and former smokers: Longitudinal evaluation in the U.S. population. Drug Alcohol Depend 127:170-176.
8. Hall SM, Munoz RF, Reus VI, Sees KL, Duncan C, Humfleet GL, Hartz DT (1996): Mood management and nicotine gum in smoking treatment: A therapeutic contact and placebo-controlled study. J Consult Clin Psychol 64:1003-1009.
9. Lerman C, Audrain J, Orleans CT, Boyd R, Gold K, Main D, Caporaso N (1996): Investigation of mechanisms linking depressed mood to nicotine dependence. Addict Behav 21:9-19.
10. Levine MD, Marcus MD, Perkins KA (2003): A history of depression and smoking cessation outcomes among women concerned about post-cessation weight gain. Nicotine Tob Res 5:69-76.
11. Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R (2001): Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav 15: 13-17.
12. Tsoh JY, Hall SM (2004): Depression and smoking: From the Transtheoretical Model of change perspective. Addict Behav 29:801-805.
13. Weinberger AH, Mazure CM, Morlett A, McKee SA (2013): Two decades of smoking cessation treatment research on smokers with depression: 1990-2010. Nicotine Tob Res 15:1014-1031.
14. Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA (2012): The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: Longitudinal evaluation in the US population. Addiction 107:1847-1856.
15. Lerman C, Audrain-McGovern J (2010): Reinforcing effects of smoking: More than a feeling. Biol Psychiatry 67:699-701.
16. Perkins KA, Karelitz JL, Conklin CA, Sayette MA, Giedgowd GE (2010): Acute negative affect relief from smoking depends on the affect situation and measure but not on nicotine. Biol Psychiatry 67: 707-714.
17. Brown RA, Niaura R, Lloyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, et al. (2007): Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res 9: 721-730.
18. Cinciripini PM, Wetter DW, Fouladi RT, Blalock JA, Carter BL, Cinciripini LG, Baile WF (2003): The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. J Consult Clin Psychol 71:292-301.
19. Covey LS, Glassman AH, Stetner F, Rivelli S, Stage K (2002): A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am J Psychiatry 159:1731-1737.
20. Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M (2008): A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol 28:660-666.
21. Haas AL, Munoz RF, Humfleet GL, Reus VI, Hall SM (2004): Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J Consult Clin Psychol 72:563-570.
22. Hall SM, Humfleet GL, Reus VI, Munoz RF, Hartz DT, Maude-Griffin R (2002): Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry 59:930-936.
23. Kahler CW, Brown RA, Ramsey SE, Niaura R, Abrams DB, Goldstein M, et al. (2002): Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. J Abnorm Psychol 111: 670-675.
24. Strong DR, Kahler CW, Leventhal AM, Abrantes AM, Lloyd-Richardson E, Niaura R, Brown RA (2009): Impact of bupropion and cognitivebehavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. Nicotine Tob Res 11: 1142-1153.
25. Burgess ES, Brown RA, Kahler CW, Niaura R, Abrams DB, Goldstein MG, Miller IW (2002): Patterns of change in depressive symptoms during smoking cessation: Who's at risk for relapse? J Consult Clin Psychol 70:356-361.
26. Forbes EE (2009): Where's the fun in that? Broadening the focus on reward function in depression. Biol Psychiatry 66:199-200.
27. Spring B, Cook JW, Appelhans B, Maloney A, Richmond M, Vaughn J, et al. (2008): Nicotine effects on affective response in depressionprone smokers. Psychopharmacology (Berl) 196:461-471.
28. Comer SD, Collins ED, Wilson ST, Donovan MR, Foltin RW, Fischman MW (1998): Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur J Pharmacol 345:13-26.
29. Epstein LH, Bulik CM, Perkins KA, Caggiula AR, Rodefer J (1991): Behavioral economic analysis of smoking: Money and food as alternatives. Pharmacol Biochem Behav 38:715-721.
30. Fisher EBJ (1996): A behavioral-economic perspective on the influence of social support on cigarette smoking. In: Green L, Kagel JH, eds. Advances in Behavioral Economics, 3, Substance Use and Abuse. Norwood, NJ: Alex Publishing Company.
31. Green L, Fisher EB (2000): Economic substitutability: Some implications for health behavior. In: Bickel WK, Vuchinich RE, eds. Reframing Health Behavior Change with Behavior Economics. Mahwah, NJ: Lawrence Erlbaum Associates.
32. Green L, Freed DE (1993): The substitutability of reinforcers. J Exp Anal Behav 60:141-158.
33. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ (1994): Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 51:568-576.
34. Perkins KA, Hickcox ME, Grobe JE (2000): Behavioral economics of tobacco smoking. In: Bickel WK, Vuchinich RE, eds. Reframing Health Behavior Change with Behavior Economics. Mahwah, NJ: Lawrence Erlbaum Associates.
35. Bickel WK, DeGrandpre RJ, Higgins ST (1995): The behavioral economics of concurrent drug reinforcers: A review and reanalysis of drug selfadministration research. Psychopharmacology (Berl) 118:250-259.
36. Campbell UC, Carroll ME (2000): Reduction of drug selfadministration by an alternative non-drug reinforcer in rhesus monkeys: Magnitude and temporal effects. Psychopharmacology (Berl) 147:418-425.
37. Jacobson NS, Dobson KS, Truax PA, Addis ME, Koerner K, Gollan JK, et al. (1996): A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol 64:295-304.
38. Lewinsohn PM, Amenson CS (1978): Some relations between pleasant and unpleasant mood-related events and depression. J Abnorm Psychol 87:644-654.
39. MacPhillamy DJ, Lewinsohn PM (1974): Depression as a function of levels of desired and obtained pleasure. J Abnorm Psychol 83: 651-657.
40. Dunn BD, Dalgleish T, Lawrence AD, Cusack R, Ogilvie AD (2004): Categorical and dimensional reports of experienced affect to emotioninducing pictures in depression. J Abnorm Psychol 113:654-660.
41. Forbes EE, Shaw DS, Dahl RE (2007): Alterations in reward-related decision making in boys with recent and future depression. Biol Psychiatry 61:633-639.
42. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M (2008): Reduced hedonic capacity in major depressive disorder: Evidence from a probabilistic reward task. J Psychiatr Res 43:76-87.
43. Shankman SA, Klein DN, Tenke CE, Bruder GE (2007): Reward sensitivity in depression: A biobehavioral study. J Abnorm Psychol 116:95-104.
44. Sloan DM, Strauss ME, Quirk SW, Sajatovic M (1997): Subjective and expressive emotional responses in depression. J Affect Disord 46: 135-141.
45. Wichers MC, Barge-Schaapveld DQ, Nicolson NA, Peeters F, de Vries M, Mengelers R, van Os J (2009): Reduced stress-sensitivity or increased reward experience: The psychological mechanism of response to antidepressant medication. Neuropsychopharmacology 34:923-931.
46. Clark LA, Watson D, Mineka S (1994): Temperament, personality, and the mood and anxiety disorders. J Abnorm Psychol 103:103-116.
47. Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, et al. (2009): Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 166:64-73.
48. Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL, et al. (2007): The other face of depression, reduced positive affect: The role of catecholamines in causation and cure. J Psychopharmacol 21:461-471.
49. Spring B, Pingitore R, McChargue DE (2003): Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am J Psychiatry 160:316-322.
50. Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, et al. (2009): Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol Psychiatry 66:898-901.
51. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA, Sayette MA (2010): Differences in negative mood-induced smoking reinforcement due to distress tolerance, anxiety sensitivity, and depression history. Psychopharmacology (Berl) 210:25-34.
52. Barr RS, Pizzagalli DA, Culhane MA, Goff DC, Evins AE (2008): A single dose of nicotine enhances reward responsiveness in nonsmokers: Implications for development of dependence. Biol Psychiatry 63: 1061-1065.
53. Kenny PJ, Markou A (2006): Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31:1203-1211.
54. Johnson PM, Hollander JA, Kenny PJ (2008): Decreased brain reward function during nicotine withdrawal in C57BL6 mice: Evidence from intracranial self-stimulation (ICSS) studies. Pharmacol Biochem Behav 90:409-415.
55. Perkins KA, Doyle T, Ciccocioppo M, Conklin C, Sayette M, Caggiula A (2006): Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology (Berl) 184:600-607.
56. Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG, et al. (1998): Nicotine-induced limbic cortical activation in the human brain: A functional MRI study. Am J Psychiatry 155:1009-1015.
57. Warburton DM, Mancuso G (1998): Evaluation of the information processing and mood effects of a transdermal nicotine patch. Psychopharmacology (Berl) 135:305-310.
58. al'Absi M, Hatsukami D, Davis GL, Wittmers LE (2004): Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend 73:267-278.
59. Cook JW, Spring B, McChargue D (2007): Influence of nicotine on positive affect in anhedonic smokers. Psychopharmacology (Berl) 192: 87-95.
60. Cook JW, Spring B, McChargue D, Hedeker D (2004): Hedonic capacity, cigarette craving, and diminished positive mood. Nicotine Tob Res 6:39-47.
61. Miller PG, Miller WR (2009): What should we be aiming for in the treatment of addiction? Addiction 104:685-686.
62. Hitsman B, Papandonatos GD, McChargue DE, DeMott A, Herrera MJ, Spring B, et al. (2013): Past major depression and smoking cessation outcome: A systematic review and meta-analysis update. Addiction 108:294-306.
63. Zimmerman M, Coryell W (1987): The inventory to diagnose depression, lifetime version. Acta Psychiatr Scand 75:495-499.
64. Zimmerman M, Coryell W, Corenthal C, Wilson S (1986): A self-report scale to diagnose major depressive disorder. Arch Gen Psychiatry 43: 1076-1081.
65. Kinnunen T, Korhonen T, Garvey AJ (2008): Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: Twelvemonth results of a randomized placebo controlled trial. Int J Psychiatry Med 38:373-389.
66. Radloff LS (1977): The CES-D scale: A self-report depression scale for research in the general population. Appl Psych Meas 1:385-401.
67. Perkins KA, Grottenthaler A, Wilson AS (2009): Lack of reinforcement enhancing effects of nicotine in non-dependent smokers. Psychopharmacology (Berl) 205:635-645.
68. Lussier JP, Higgins ST, Badger GJ (2005): Influence of the duration of abstinence on the relative reinforcing effects of cigarette smoking. Psychopharmacology (Berl) 181:486-495.
69. Perkins KA, Epstein LH, Grobe J, Fonte C (1994): Tobacco abstinence, smoking cues, and the reinforcing value of smoking. Pharmacol Biochem Behav 47:107-112.
70. Yoon JH, Higgins ST, Bradstreet MP, Badger GJ, Thomas CS (2009): Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence. Psychopharmacology (Berl) 205: 305-318.
71. Perkins KA, Jacobs L, Sanders M, Caggiula AR (2002): Sex differences in the subjective and reinforcing effects of cigarette nicotine dose. Psychopharmacology (Berl) 163:194-201.
72. Perkins KA, Karelitz JL (2013): Reinforcement enhancing effects of nicotine via smoking. Psychopharmacology (Berl) 228:479-486.
73. Bickel WK, Marsch LA, Carroll ME (2000): Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: A theoretical proposal. Psychopharmacology (Berl) 153:44-56.
74. Epstein LH, Leddy JJ, Temple JL, Faith MS (2007): Food reinforcement and eating: A multilevel analysis. Psychol Bull 133:884-906.
75. Bogdan R, Pizzagalli DA (2006): Acute stress reduces reward responsiveness: Implications for depression. Biol Psychiatry 60:1147-1154.
76. Pizzagalli DA, Jahn AL, O'Shea JP (2005): Toward an objective characterization of an anhedonic phenotype: A signal-detection approach. Biol Psychiatry 57:319-327.
77. Hufford MR (2007): Special methodological challenges and opportunities in ecological momentary assessment. In: Stone AA, Shiffman SS, Atienza AA, Nebeling L, eds. The Science of Real-Time Data Capture: Self-Reports in Health Research. New York: Oxford University Press, 54-75.
78. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR (2002): Patient non-compliance with paper diaries. BMJ 324:1193-1194.
79. Shiffman S, Balabanis MH, Gwaltney CJ, Paty JA, Gnys M, Kassel JD, et al. (2007): Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment. Drug Alcohol Depend 91:159-168.
80. Shiffman S, Gwaltney CJ, Balabanis MH, Liu KS, Paty JA, Kassel JD, et al. (2002): Immediate antecedents of cigarette smoking: An analysis from ecological momentary assessment. J Abnorm Psychol 111:531-545.
81. Juliano LM, Donny EC, Houtsmuller EJ, Stitzer ML (2006): Experimental evidence for a causal relationship between smoking lapse and relapse. J Abnorm Psychol 115:166-173.
82. Perkins KA, Lerman C, Fonte CA, Mercincavage M, Stitzer ML, Chengappa KN, Jain A (2010): Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin Pharmacol Ther 88:109-114.
83. Perkins KA, Karelitz JL, Jao NC (2013): Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine Tob Res 15:978-982.
84. Cooke F, Bullen C, Whittaker R, McRobbie H, Chen MH, Walker N (2008): Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res 10:607-612.
85. Macmillan NA, Creelman CD (2005): Detection Theory: A User's Guide, 2nd ed. Mahway, NJ: Lawrence Erlbaum Associates Publishers.
86. Freedman MJ, Lester KM, McNamara C, Milby JB, Schumacher JE (2006): Cell phones for ecological momentary assessment with cocaineaddicted homeless patients in treatment. J Subst Abuse Treat 30:105-111.
87. Shiffman S (2007): Designing protocols for ecological momentary assessment. In: Stone AA, Shiffman SS, Atienza AA, Nebeling L, eds. The Science of Real-Time Data Capture: Self-Reports in Health Research. New York: Oxford University Press, 27-53.
88. Carter BL, Lam CY, Robinson JD, Paris MM, Waters AJ, Wetter DW, Cinciripini PM (2008): Real-time craving and mood assessments before and after smoking. Nicotine Tob Res 10:1165-1169.
89. Epstein DH, Marrone GF, Heishman SJ, Schmittner J, Preston KL (2010): Tobacco, cocaine, and heroin: Craving and use during daily life. Addict Behav 35:318-324.
90. Weinstein SM, Mermelstein R (2007): Relations between daily activities and adolescent mood: The role of autonomy. J Clin Child Adolesc Psychol 36:182-194.
91. Snuggs S, Hajek P (2013): Responsiveness to reward following cessation of smoking. Psychopharmacology (Berl) 225:869-873.
92. Gwaltney CJ, Bartolomei R, Colby SM, Kahler CW (2008): Ecological momentary assessment of adolescent smoking cessation: A feasibility study. Nicotine Tob Res 10:1185-1190.
93. Weinstein SM, Mermelstein R, Shiffman S, Flay B (2008): Mood variability and cigarette smoking escalation among adolescents. Psychol Addict Behav 22:504-513.
94. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991): The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119-1127.
95. Hughes JR, Hatsukami D (1986): Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289-294.
96. Watson D, Clark LA, Tellegen A (1988): Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 54:1063-1070.
97. Audrain-McGovern J, Rodriguez D, Rodgers K, Cuevas J (2011): Declining alternative reinforcers link depression to young adult smoking. Addiction 106:178-187.
98. Audrain-McGovern J, Rodriguez D, Epstein LH, Rodgers K, Cuevas J, Wileyto EP (2009): Young adult smoking: What factors differentiate ex-smokers, smoking cessation treatment seekers and nontreatment seekers? Addict Behav 34:1036-1041.
99. Correia CJ, Simons J, Carey KB, Borsari BE (1998): Predicting drug use: Application of behavioral theories of choice. Addict Behav 23:705-709.
100. Van Etten ML, Higgins ST, Budney AJ, Badger GJ (1998): Comparison of the frequency and enjoyability of pleasant events in cocaine abusers vs. non-abusers using a standardized behavioral inventory. Addiction 93:1669-1680.
101. Jamal M, Does AJ, Penninx BW, Cuijpers P (2011): Age at smoking onset and the onset of depression and anxiety disorders. Nicotine Tob Res 13:809-819.
102. Peiper N, Rodu B (2013): Evidence of sex differences in the relationship between current tobacco use and past-year serious psychological distress: 2005-2008 National Survey on Drug Use and Health. Soc Psychiatry Psychiatr Epidemiol 48:1261-1271.
103. Pratt LA, Brody DJ (2010): Depression and smoking in the U.S. household population aged 20 and over, 2005-2008. NCHS Data Brief 34:1-8.
104. MacPherson L, Tull MT, Matusiewicz AK, Rodman S, Strong DR, Kahler CW, et al. (2010): Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol 78:55-61.
105. Duckworth LA, Steen TA, Seligman ME (2005): Positive psychology in clinical practice. Annu Rev Clin Psychol 1:629-651.
106. Seligman ME, Steen TA, Park N, Peterson C (2005): Positive psychology progress: Empirical validation of interventions. Am Psychol 60:410-421.
107. Levin ME, Weaver MT, Palmatier MI, Caggiula AR, Sved AF, Donny EC (2012): Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcementenhancing effects of nicotine. Nicotine Tob Res 14:299-305.
108. Perkins KA, Karelitz JL, Jao NC, Stratton E (2013): Possible reinforcement enhancing effects of bupropion during initial smoking abstinence. Nicotine Tob Res 15:1141-1145.
109. Siegle GJ, Carter CS, Thase ME (2006): Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 163:735-738.
110. Dichter GS, Felder JN, Petty C, Bizzell J, Ernst M, Smoski MJ (2009): The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry 66:886-897.
111. Cuthbert BN (2014): The RDoC framework: Facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 13:28-35.
112. Treadway MT, Zald DH (2011): Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neurosci Biobehav Rev 35:537-555.
113. Vrieze E, Pizzagalli DA, Demyttenaere K, Hompes T, Sienaert P, de Boer P, et al. (2013): Reduced reward learning predicts outcome in major depressive disorder. Biol Psychiatry 73:639-645.
114. Davidson RJ (2003): Affective neuroscience and psychophysiology: Toward a synthesis. Psychophysiology 40:655-665.